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Depletion of myocardial glucose is observed
during endotoxemic but not hemorrhagic shock
in a porcine model
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Abstract
Introduction: Metabolic dysfunction is one of the hallmarks of sepsis yet little is known about local changes in key
organs such as the heart. The aim of this study was to compare myocardial metabolic changes by direct
measurements of substrates, such as glucose, lactate and pyruvate, using microdialysis (MD) in in-vivo porcine
endotoxemic and hemorrhagic shock. To assess whether these changes were specific to the heart, we
simultaneously investigated substrate levels in skeletal muscle.
Methods: Twenty-six female pigs were randomized to three groups: control (C) n = 8, endotoxemic shock (E)
n = 9 and hemorrhagic shock (H) n = 9. Interstitial myocardial pyruvate, lactate and glucose were measured
using MD. Skeletal muscle MD was also performed in all three groups.
Results: Marked decreases in myocardial glucose were observed in the E group but not in the H group compared
to controls (mean difference (CI) in mmol/L: C versus E -1.5(-2.2 to -0.8), P <0.001; H versus E -1.1(-1.8 to -0.4),
P = 0.004; C versus H -0.4(-1.1 to 0.3), P = 0.282). Up to four-fold increases in myocardial pyruvate and three-fold
increases in lactate were seen in both shock groups with no differences between the two types of shock. There
was no evidence of myocardial anaerobic metabolism, with normal lactate:pyruvate (L:P) ratios seen in all animals
regardless of the type of shock.
In skeletal muscle, decreases in glucose concentrations were observed in the E group only (mean difference:
C versus E -0.8(-1.4 to -0.3), P = 0.007). Although skeletal muscle lactate increased in both shock groups, this was
accompanied by increases in pyruvate in the E group only (mean difference: C versus E 121(46 to 195), P = 0.003;
H versus E 77(7 to 147), P = 0.032; C versus H 43(-30 to 43), P = 0.229). The L:P ratio was increased in skeletal
muscle in response to hemorrhagic, but not endotoxemic, shock.
Conclusions: Endotoxemia, but not hemorrhage, induces a rapid decrease of myocardial glucose levels. Despite
the decrease in glucose, myocardial lactate and pyruvate concentrations were elevated and not different than in
hemorrhagic shock. In skeletal muscle, substrate patterns during endotoxemic shock mimicked those seen in
myocardium. During hemorrhagic shock the skeletal muscle response was characterized by a lack of increase in
pyruvate and higher L:P ratios.
Hence, metabolic patterns in the myocardium during endotoxemic shock are different than those seen during
hemorrhagic shock. Skeletal muscle and myocardium displayed similar substrate patterns during endotoxemic
shock but differed during hemorrhagic shock.
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Introduction
Imbalance in myocardial energy metabolism has been
proposed as one of the mechanisms behind cardiac dys-
function associated with sepsis [1,2]. Despite the fact that
myocardial utilization of energy substrates and contracti-
lity are inextricably linked [3], the extent of metabolic
changes in the myocardium and whether they may be a
cause of cardiac dysfunction in sepsis remain undefined.
The myocardium has a unique ability to utilize multiple
substrates for energy production. Free fatty acids (FFAs)
are the major fuel for the heart (60% to 100%) with a les-
ser contribution from glucose and lactate (0 to 20% each)
[4]. In patients with septic shock changes in myocardial
metabolism have been demonstrated [5] with reported
increases in myocardial lactate uptake and decreases in
free fatty acid and glucose utilization. However, the sub-
strates involved in myocardial metabolism have generally
been measured indirectly using coronary sinus sampling
or in ex-vivo heart preparations. Further, it is not known
if there is a specific pattern of changes for sepsis and if
these only apply to cardiac muscle. Impairment of glu-
cose metabolism has been demonstrated in experimental
models of septic shock [6,7]. Emerging data suggest that
endotoxemic shock may induce distinct changes in the
myocardial metabolism that includes an accelerated aero-
bic glycolytic process resulting in glucose depletion and
accumulation of pyruvate [8].These distinctive changes
have also been reported in skeletal muscle during endo-
toxemic shock but not during hemorrhagic shock [8,9].
Possible explanations for this include catecholamine
overdrive resulting in increased Na+ K+ ATPase activity,
mitochondrial dysfunction and pyruvate dehydrogenase
inhibition. It is likely that endotoxemia, hemorrhage and
other mechanisms of shock have variable effects on car-
diac and skeletal muscle metabolism and this may have
implications for clinical management of these conditions.
This is highly relevant as approximately 15% of deaths
related to septic shock have been attributed to myocar-
dial depression [10].
Carbohydrate metabolism and its regulation in the
myocardium is complex and is dependent on arterial sub-
strate levels, coronary blood flow, hormonal levels in the
blood, nutritional reserve of the heart and the inotropic
state [11]. In the stressed heart, there is a switch from
FFAs to other energy substrates as the preferred meta-
bolic fuel [12]. This metabolic flexibility may confer an
adaptive advantage to an organ with high energy require-
ments; indeed, loss of this flexibility leads to maladapta-
tion in conditions such as chronic heart failure and
diabetic cardiomyopathy. Little is known about myocar-
dial energetics in sepsis. The absence of demonstrable
myocardial ischemia in multiple studies [8,13] during
sepsis and shock raises important questions about myo-
cardial energy metabolism during shock states that are
often associated with cardiac dysfunction. Our current
understanding of myocardial metabolism is largely based
on studies that used global markers or measurements
from regional blood samples. There are few studies that
have used microdialysis (MD) techniques to describe
changes in cardiac metabolism. MD provides a unique
opportunity to study temporal changes directly in tissues
in response to a physiological insult and is a novel way of
studying metabolism without the need for repeated biop-
sies or inference from blood samples. Most of the avail-
able myocardial MD studies are limited to conditions of
cardiac ischemia, infarction and cardiopulmonary bypass
and only a few have been published within the setting of
septic or hemorrhagic shock. The understanding of myo-
cardial metabolism in shock states is important as it may
lead to pharmacological interventions that can improve
cardiac performance by regulating the energy mechan-
isms of the heart.
The aim of this study was to compare the metabolic
changes in the myocardium using MD in porcine mod-
els of shock resulting from endotoxemia and hemor-
rhage. To assess whether these changes were specific to
the heart, we simultaneously investigated substrate levels
in skeletal muscle.
Materials and methods
The study was approved by the Swedish National Board
for Animal Experimentation (Case number M131-09)
and conforms to the guidelines laid out in the Guide for
the Care and Use of Laboratory Animals from the
National Research Council. Twenty-six female pigs,
weighing 32 to 41 kg, were used in the study and were
randomized to three groups: control (C) n = 8, endo-
toxemic shock (E) n = 9 and hemorrhagic shock (H)
n = 9.
Anesthesia, mechanical ventilation and fluids
The porcine endotoxemic model has been previously
described [8]. After premedication with xylazine 2 mg/kg
IM and ketamine 20 mg/kg IM, general anesthesia was
induced with thiopentone 5 mg/kg. General anesthesia
was maintained with ketamine 5 mg/kg/hr, midazolam
0.5 mg/kg/hr and fentanyl 10 mcg/kg/hr IV. All animals
were intubated and mechanically ventilated with a
Siemens 900 Ventilator (Siemens Elema, Stockholm,
Sweden). Ventilator settings were adjusted to maintain
PaCO2 between 4.5 and 6.0 kPa and SaO2 over 95%.
Ringer’s acetate 10 ml/kg/hr was infused to compensate
for fluid loses and an additional 500 ml was given before
the induction of shock.
Monitoring
All animals were monitored with (three-lead ECGs,)
invasive arterial blood pressure measurement, SpO2 and
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hourly urine output. Arterial blood gases were drawn
every two hours for adjustment of ventilator settings.
Instrumentation
The external jugular veins were exposed bilaterally by sur-
gical cut-down. A central venous catheter was inserted for
drug and fluid infusion. The contralateral external jugular
vein was used for the insertion of a pulmonary artery
catheter (PAC). This was used for hourly measurements of
central venous pressure (CVP), mean pulmonary arterial
pressure (MPAP) and pulmonary capillary wedge pressure
(PCWP).
The left or right carotid artery was also exposed by
surgical cut-down, and an arterial catheter was inserted
for blood gas sampling.
The left or right femoral artery was also exposed surgi-
cally and an arterial catheter was inserted for bleed-out in
the animals assigned to the hemorrhagic shock groups. A
midline thoracotomy was performed and the pericardium
divided, suspending the heart in a pericardial sling. A MD
catheter (CMA 20, CMA Microdialysis, Solna Sweden)
was inserted into the anterior surface of the myocardium,
immediately adjacent and parallel to the diagonal branches
of the left anterior descending artery. The catheters were
perfused with Ringer’s acetate at 0.3 uL/minute. MD
catheters were left in-situ for at least one hour for stabili-
zation before microdialysate samples were collected.
The pericardial cavity was filled with saline solution
and ultrasound gel to provide acoustic coupling for
transepicardial echocardiographic imaging.
Via direct surgical exposure a MD catheter (CMA 20,
CMA Microdialysis, Solna, Sweden) was inserted into
the gluteus maximus muscle. The catheters were per-
fused with Ringer’s acetate at 0.3 uL/minute. Microdia-
lysis catheters were left in-situ for at least one hour for
stabilization before microdialysate samples were
collected.
The urinary bladder was catheterized using a suprapubic
approach and urine output (UO) measured hourly.
Induction of endotoxemia
Endotoxemia was induced using Escherichia coli lipopo-
lysaccharide (LPS O111:B4, product code L2630, Sigma
Aldrich, St Louis, MO, USA) at an infusion rate of
5 ug/kg/hour for the first hour followed by 2.5 ug/kg/
hour for the remaining duration of the experiment.
Induction of hemorrhagic shock
A bleed out of 30% blood volume was made via a
femoral arterial catheter assuming a blood volume of 76
ml/kg for all pigs [14]. Bleed out was performed at a
rate of 2 ml/kg/minute for five minutes, followed by
1 ml/kg/minute for 12.5 minutes.
Measurements
The following systemic hemodynamic measurements
were recorded hourly: mean arterial pressure (MAP),
MPAP, PCWP, CVP, mixed venous oxygen saturation
(SmvO2), cardiac index (CI) and systemic vascular resis-
tance index (SVRI). The following parameters were cal-
culated: stroke volume index (SVi), oxygen delivery
index (DO2i), oxygen consumption index (VO2i), left
ventricular stroke work index (LVSWI), right ventricular
stroke work index (RVSWI) and oxygen extraction ratio
(O2ER).
Urine output was recorded hourly.
Microdialysate samples in the myocardial and skeletal
muscle interstitium were collected every hour for the
measurement of interstitial glucose, lactate and pyruvate
and for the calculation of lactate to pyruvate ratios (L:P).
Analyses of these metabolites were made on an ISCUSflex
microdialysis analyzer {AU Query: Please indicate the
manufacturer of the microdialysis analyzer - city, state (if
applicable), country.}(M-dialysis, Solna, Sweden) accord-
ing to the manufacturer’s instructions. This analyzer uses
enzymatic reagents and colorimetric assays, with an assay
imprecision of <4%.
Transthoracic echocardiographic images of the heart
were obtained from the apex using a direct epicardial
approach. Four-chamber and two -chamber views are
obtained. Left ventricular (LV) systolic function was
evaluated using ejection fraction by eyeballing (EF), velo-
city time integral at the left ventricular outflow tract
(VTI) and the average of septal and lateral tissue Dop-
pler velocities (TDI). LV diastolic function was evaluated
using the mitral early to late inflow velocity ratio (E/A)
and mitral early inflow to tissue Doppler velocity ratio
(E/é). Right ventricular function was assessed as the tri-
cuspid annular plane systolic excursion (TAPSE) and
the pressure gradient between the right atrium and ven-
tricle (TR).
Statistics
A mixed model analysis with a random intercept for
each pig was used to control for between-pig differ-
ences. We modeled each response over time with group
(C, E or H) as independent variables. Baseline response
was included as a covariate in order to control for
regression to the mean. No linear assumptions were
made for the change over time. We calculated the aver-
age difference between groups over all times (with a
95% confidence interval) and the maximum difference
over hours one to six. P-values less than 0.05 were con-
sidered statistically significant. Skewed data were log-
transformed. All analyses were conducted using R
(www.r-project.org) and Sigma Stat version 3.5 (Systat
Software, San Jose, California, USA).
Chew et al. Critical Care 2013, 17:R164
http://ccforum.com/content/17/4/R164
Page 3 of 10
Results
Hemodynamic parameters
Hemodynamic alterations in the E group were character-
ized by significant increases in heart rate (HR) and MPAP
and decreases in MAP, SVI and LVSWI compared to the
control group. RVSWI increased, reflecting increases in
pulmonary arterial pressures, a finding supported by echo-
cardiography parameters. There were trends to decreased
SmvO2 but these changes were short-lived, reaching sta-
tistical significance only within the first two hours of endo-
toxemia. Arterial lactate concentrations increased
significantly, up to three-fold compared to controls.
Despite the decrease in MAP and increases in HR and
arterial lactate concentration (A-lac), DO2i, VO2i and
O2ER were relatively preserved. In the hemorrhage group
significant increases were observed in O2ER and decreases
in MAP, CVP, PCWP, DO2i, LVSWI and RVSWI com-
pared to C and E animals. A-lac increased 2.5-fold.
There were no significant changes in arterial glucose
concentrations in any of the groups over time nor
between the groups (data not shown).
Echocardiography
There were significant decreases in LV systolic function
as assessed by EF in the E group compared to the C and
H groups. EF increased slightly in the H group and
decreased in the E group, with statistically significant
differences between the two shock groups from four
hours post endotoxemia (t4) onwards. LV diastolic func-
tion, measured as E/A and E/é remained unchanged in
all three groups.
VTI significantly decreased in the H group and was
significantly different from the C group. VTI was also
decreased in the E group, but this did not reach statisti-
cal significance (P = 0.056).
RV function measured by TAPSE was decreased in the
E and but not the C or H groups with maximal differ-
ences towards the end of the observation period.
Reflecting decreased RV function, TR was higher in the
E group, differing significantly from the H group.
Hemodynamic and echocardiographic parameters are
shown in Table 1.
Microdialysis
Myocardial metabolites in controls, endotoxemic and
hemorrhagic shock
Mean and maximum differences between the groups are
shown in Table 2.
Marked decreases in myocardial glucose were
observed in the E group towards the end of the study
period (nadir 0.6 (0.5 to 0.8) mmol/L, P < 0.001 com-
pared to baseline) whereas they remained relatively
Table 1 Hemodynamic and echocardiographic parameters
Mean difference (CI) P(mean) Max difference (CI) P(max)
HR (bpm) C vs H 12.7(-1.7 to 27.2) NS(0.081) 18.4(-1.3 to 38.2) NS(0.066)
C vs E 16.3(2.0 to 30.5) 0.027 25.6(6.0 to 45.2) 0.013
H vs E 3.5(-10.6 to 17.7) NS(0.609) N/A NS(0.151)
MAP (mmHg) C vs H -34.0(-44.7 to -23.3) <0.001 -48.6(-61.4 to -35.8) <0.001
C vs E -9.8(-20.6 to 1.1) NS(0.075) -29.9(-42.8 to -17.0) <0.001
H vs E 24.3(14.2 to 34.3) <0.001 29.1(16.6 to 41.6) <0.001
MPAP (mmHg) C vs H -3.5(-7.0 to -0.1) 0.047 unable to identify sig. changes NS(0.107)
C vs E 10.9(7.2 to 14.7) <0.001 19.4(14.4 to 24.4) <0.001
H vs E 14.5(10.8 to 18.1) <0.001 23.3(18.4 to 28.1) <0.001
CVP (mmHg) C vs H -1.8(-3.4 to -0.2) 0.029 -2.4(-4.3 to -0.4) 0.020
C vs E -0.3(-1.8 to 1.3) NS(0.722) N/A NS(0.295)
H vs E 1.5(0.1 to 3.0) 0.041 2.9(1.0 to 4.7) 0.004
PCWP (mmHg) C vs H -2.4(-4.0 to -0.9) 0.004 -3.0(-5.0 to -0.9) 0.008
C vs E 0.5(-1.0 to 2.1) NS(0.464) 2.9(0.9 to 5.0) 0.007
H vs E 3.0(1.5 to 4.4) <0.001 5.1(3.2 to 7.1) <0.001
SVI (ml/m2) C vs H -8.2(-12.5 to -3.8) 0.001 -10.5(-16.6 to -4.5) 0.002
C vs E -6.0(-10.3 to -1.7) 0.008 -7.8(-13.8 to -1.7) 0.014
H vs E 2.1(-2.3 to 6.5) NS(0.322) 5.4(-0.6 to 11.4) NS(0.076)
SmvO2 (%) C vs H -23.8(-32.9 to -14.7) <0.001 -33.4(-45.4 to -21.4) <0.001
C vs E -6.1(-15.2 to 3.0) NS(0.178) -14.9(-26.9 to -2.9) 0.017
H vs E 17.7(9.2 to 26.2) <0.001 19.2(8.0 to 30.4) 0.002
A-Lac (mmol/L) C vs H 2.3(0.6 to 4.1) 0.011 2.7(0.7 to 4.7) 0.010
C vs E 2.8(1.0 to 4.6) 0.003 3.3(1.3 to 5.3) 0.003
H vs E 0.5(-1.1 to 2.1) NS(0.529) N/A NS(0.188)
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Table 1 Hemodynamic and echocardiographic parameters (Continued)
DO2i (ml/min/m2) C vs H -96.2(-157.2 to -35.2) 0.004 -113.6(-185.7 to -41.5) 0.004
C vs E 1.6(-61.5 to 64.6) NS(0.959) N/A NS(0.536)
H vs E 97.8(35.5 to 160.0) 0.004 120.1(47.0 to 193.1) 0.003
VO2i (ml/min/m2) C vs H 0.7(-28.8 to 30.2) NS(0.962) N/A NS(0.275)
C vs E 14.8(-17.0 to 46.6) NS(0.343) N/A NS(0.242)
H vs E 14.1(-16.6 to 44.8) NS(0.349) N/A NS(0.210)
O2ER C vs H 0.2 (0.2 to 0.3) <0.001 0.3(0.2 to 0.4) <0.001
C vs E 0.1(0.0 to 0.2) NS(0.119) 0.1(0.0 to 0.2) 0.029
H vs E -0.2(-0.3 to -0.1) <0.001 -0.2(-0.1 to -0.3) 0.001
LVSWI (g.mm2) C vs H -16.9(-22.6 to -11.2) <0.001 -24.4(-31.4 to -17.3) <0.001
C vs E -9.1(-14.7 to -3.6) 0.003 -17.2(-24.2 to -10.3) <0.001
H vs E 7.8(2.3 to 13.3) 0.008 9.5(2.3 to 16.7) 0.012
RVSWI (g.mm2) C vs H -2.2(-4.0 to -0.5) 0.016 -2.6(-4.9 to -0.3) 0.031
C vs E 2.0(0.2 to 3.8) 0.027 4.9(2.6 to 7.2) <0.001
H vs E 4.2(2.5 to 6.0) <0.001 7.5(5.2 to 9.7) <0.001
EF (%) C vs H 2.9(-1.8 to 7.5) NS(0.210) N/A NS(0.263)
C vs E -9.5(-14.4 to -4.7) 0.001 -10.5(-16.6 to -4.5) 0.002
H vs E -12.4(-17.0 to -7.8) <0.001 -13.1(-18.9 to -7.4) <0.001
TDI (mm) C vs H -0.5(-1.1 to 0.2) NS(0.143) -1.0(-2.1 to 0.0) NS(0.055)
C vs E -0.4(-1.1 to 0.2) NS(0.182) -1.0(-2.2 to 0.2) NS(0.092)
H vs E 0.0(-0.6 to 0.7) NS(0.943) N/A NS(0.462)
VTI (cm) C vs H -4.0(-6.3 to -1.8) 0.001 -5.7(-8.4 to -3.1) <0.001
C vs E -2.2(-4.5 to 0.1) NS(0.056) -2.8(-5.6 to 0.0) 0.048
H vs E 1.8(-0.4 to 4.0) NS(0.099) 3.8(1.3 to 6.3) 0.005
TAPSE (mm) C vs H -1.2(-3.5 to 1.0) 0.268 -2.7(-5.5 to 0.1) NS(0.060)
C vs E -3.0(-5.1 to -0.9) 0.008 -4.0(-6.7 to -1.3) 0.006
H vs E -1.8(-3.9 to 0.4) NS(0.105) -3.3(-5.9 to -0.6) 0.018
TR (mmHg) C vs H -1.7(-10.7 to 7.3) NS(0.695) N/A NS(0.441)
C vs E 8.3(-0.8 to 17.4) NS(0.070) 10.3(-0.4 to 21.1) NS(0.059)
H vs E 10.0(2.0 to 18.1) 0.018 14.5(5.0 to 24.0) 0.005
E/A C vs H 0.1(-0.2 to 0.4) NS(0.491) N/A NS(0.098)
C vs E -0.3(-0.7 to 0.0) 0.034 -0.5(-0.8 to -0.1) 0.015
H vs E -0.5(-0.8 to -0.2) 0.005 -0.6(-1.0 to -0.2) 0.004
E/é C vs H 2.5(0 to 5.1) 0.051 4.0(0.3 to 7.7) 0.036
C vs E -1.5(-4.1 to 1.1) NS(0.236) N/A NS(0.066)
H vs E -4.0(-1.6 to -6.5) 0.002 -5.5(-8.9 to -2.1) 0.003
Mean and maximum differences from baseline and CI are given. A positive mean or maximum difference indicates increased values in H or E groups compared
to controls (C versus H and C versus E) and vice versa. Similarly, for H versus E a positive mean or maximum difference indicates an increase in the E group
compared to the H group. P(mean) refers to intergroup differences over time using mixed models analysis. P(max) refers to post-hoc analyses at the time of
maximal difference and are given as unadjusted P-values. A-lac, arterial lactate concentration; C, control group; CVP, central venous pressure; DO2i, oxygen
delivery index; E; endotoxemic group; E/A, mitral early to late flow ratio; E/é, mitral early flow to tissue Doppler velocity ratio; EF, ejection fraction; H, hemorrhagic
group; HR,heart rate; LVSWI, left ventricular stroke work index; MAP, mean arterial pressure; MPAP, mean pulmonary arterial pressure; NS, non-significant; O2ER,
oxygen extraction ratio; PCWP, pulmonary capillary wedge pressure; RVSWI, right ventricular stroke work index; SmvO2, mixed venous oxygen saturation; SVI,
stroke volume index; TAPSE, tricuspid annular plane systolic excursion; TDI, average (septal and lateral) tissue Doppler velocity; TR, right atrial-right ventricular
pressure gradient measured using tricuspid regurgitation; VO2i, oxygen consumption index; VTI, velocity time integral at the left ventricular outflow tract.
Table 2 Microdialysis parameters for myocardium and skeletal muscle
Myocardium Skeletal muscle
Mean difference(CI) P(mean) Max difference(CI) P(max) Mean difference (CI) P(mean) Max difference (CI) P(max)
Glucose Glucose
C vs H -0.4(-1.1 to 0.3) 0.282 -1.2(-2.6 to 0.3) 0.109 -0.4(-1.0 to 0.2) 0.155 -0.8(-1.5 to 0) 0.060
C vs E -1.5(-2.2 to -0.8) <0.001 -2.5(-4.0 to -0.9) 0.003 -0.8(-1.4 to -0.3) 0.007 -1.4(-2.2 to -0.6) 0.002
H vs E -1.1(-1.8 to -0.4) 0.004 -1.4(-2.8 to 0.0) 0.043 -0.4(-1.0 to 0.1) 0.111 -1.0(-1.7 to -0.2) 0.016
Chew et al. Critical Care 2013, 17:R164
http://ccforum.com/content/17/4/R164
Page 5 of 10
stable in the H group (Figure 1a). There were significant
mean differences between C versus E (P < 0.001) and H
versus E groups (P = 0.004). Post-hoc analysis revealed
significant differences between C and E animals and
between H and E animals from t3 onwards. No difference
was seen for the C versus H group. Increases in myocar-
dial pyruvate were seen in all animals, with four-fold
increases observed in H and E shock groups (Figure 2a).
There were significant mean differences between the C
and E groups (P < 0.001) and between the C and H
groups (P < 0.001) but not between the H and E animals.
Myocardial lactate levels also increased in both shock
groups (Figure 3a). Significant mean differences were
seen between the C and E groups (P = 0.032) and
between the C and H groups (P = 0.016). There were no
differences between the E and H groups. The myocar-
dial-A-lac gradient was significantly increased in the E
compared to the H group (mean difference H versus E
0.7 (CI 0 to 1.3) mmol/L, P = 0.04) but was not signifi-
cantly different from the C group (mean difference C ver-
sus E -0.3 (CI -1.0 to 0.3) mmol/L, P = 0.299). The L:P
ratio over time decreased significantly in all animals, indi-
cating no evidence of myocardial anaerobic metabolism
(Figure 4a).
Comparison between skeletal and cardiac muscle
During endotoxemic shock, myocardial and skeletal mus-
cle glucose were both significantly decreased compared to
controls with minimum concentrations reached at t5
(myocardium: nadir 0.6 (0.5 to 0.8) mmol/L, skeletal mus-
cle: nadir 0.4 (0.3 to 1.0) mmol/L; P <0.001 compared to
baseline for both organs). In contrast, hemorrhagic shock
did not significantly decrease myocardial or skeletal mus-
cle glucose compared to controls (Table 2, Figure 1a and
1b). Lactate increased significantly in both skeletal and
Table 2 Microdialysis parameters for myocardium and skeletal muscle (Continued)
Lactate Lactate
C vs H 2.5(0.5 to 4.4) 0.016 3.4(1.1 to 5.7) 0.006 2.0(0.1 to 3.9) 0.041 2.8(0.5 to 5.0) 0.018
C vs E 2.2(0.2 to 4.1) 0.032 2.7(0.4 to 4.9) 0.013 1.7(-0.2 to 3.7) 0.083 2.9(0.5 to 5.3) 0.020
H vs E -0.3(-2.2 to 1.6) 0.740 -1.7(-3.8 to 0.5) 0.118 -0.3(-2.2 to 1.6) 0.743 1.3(-1.0 to 3.6) 0.243
Pyruvate Pyruvate
C vs H 120(65 to 176) <0.001 148(65 to 232) 0.001 43(-30 to 43) 0.229 60(-37 to 157) 0.212
C vs E 136(80 to 192) <0.001 186(104 to 268) <0.001 121(46 to 195) 0.003 238(132 to 345) <0.001
H vs E 15(-34 to 65) 0.525 54(-28 to 136) 0.184 77(7 to 147) 0.032 210(109 to 311) <0.001
L:P L:P
C vs H 6.0(-1.7 to 13.7) 0.122 9.2(0.6 to 17.8) 0.087 0.4(0.2 to 1.0) 0.193 0.6(-0.1 to 1.3) 0.092
C vs E 3.7(-4.6 to 12.0) 0.363 6.7(-2.5 to 15.9) 0.142 -0.2(-0.8 to 0.5) 0.577 -0.6(-1.3 to 0.2) 0.122
H vs E -2.3(-9.8 to 5.3) 0.540 -6.0(-14.3 to 2.2) 0.144 -0.6(-1.2 to 0) 0.061 -0.9(-1.60.2) 0.014
Mean and maximum differences from baseline and CIs are given. A positive mean or maximum difference indicates increased values in H or E groups compared
to controls (C versus H and C versus E) and vice versa. Similarly, for H versus E a positive mean or maximum difference indicates an increase in the E group
compared to the H group. P(mean) refers to intergroup differences over time using mixed models analysis. P(max) refers to post-hoc analyses at the time of
maximal difference and are given as unadjusted P-values.
Figure 1 A) Myocardial and B) skeletal muscle glucose
concentrations. t0 refers to baseline measurements prior to
induction of endotoxemic or hemorrhagic shock. Significant
decreases over time were seen in the myocardium during
endotoxemic but not hemorrhagic shock compared to controls (P
<0.001). There was a similar decrease in skeletal muscle during
endotoxemic shock (P = 0.007) but not during hemorrhagic shock.
Significant differences for individual time points are marked * for C
versus H, + for C versus E, x for H versus E. C, control group; E,
endotoxemic group; H, hemorrhagic group.
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cardiac muscles, for both E and H groups with peak levels
reached at different times (E group: myocardium 3.5 ver-
sus skeletal muscle 3.9 mmol/L at t = 6; H group: myocar-
dium 3.5 versus skeletal muscle 3.0 mmol/L at t = 3)
(Figure 3a and 3b). Whereas myocardial pyruvate levels
increased in both types of shock, skeletal muscle pyruvate
increased only in response to endotoxemic shock (mean
difference C versus E P = 0.003, C versus H P = 0.229,
H versus E P = 0.032) (Table 2, Figure 2b). L:P ratios
decreased in cardiac muscle in all animals (Figure 4a). In
contrast L:P tended to increase over time for the hemor-
rhagic shock animals in skeletal muscle. For the H group
compared to the E group there was a mean difference in
L:P ratio of 0.6 (0 to 1.2), P = 0.061 and a maximum differ-
ence -0.9 (-1.6 to -0.2), P = 0.014 at t4 (Figure 4b).
Discussion
To our knowledge this is the first reported study compar-
ing myocardial metabolism using MD in models of
hemorrhagic and endotoxemic shock. The most striking
finding of this study is the precipitous decrease in myo-
cardial glucose concentrations to near-zero levels in
endotoxemic, but not hemorrhagic, shock. Despite the
decrease in myocardial glucose concentrations during
endotoxemia, similar changes in myocardial lactate and
pyruvate concentrations were measured in both hemor-
rhagic and endotoxemic shock. Therefore, endotoxemic
and hemorrhagic shock seem to be characterized by a dif-
ferent myocardial glucose response but similar pyruvate
and lactate responses.
Next, we asked if these changes were specific to the
myocardium. In skeletal muscle, endotoxemia also
induced decreases in glucose, increases in lactate, pyruvate
and preserved L:P ratios. In contrast hemorrhagic shock
did not increase skeletal muscle pyruvate. The resultant L:
P ratio in skeletal muscle was increased indicative of anae-
robic metabolism. These results demonstrate that the ske-
letal muscle responds differently to the different types of
shock. Taken together, they suggest that the heart and
Figure 2 A) Myocardial and B) skeletal muscle pyruvate
concentrations. t0 refers to baseline measurements prior to induction of
endotoxemic or hemorrhagic shock. Significant increases over time were
seen in myocardium in response to both endotoxemic and hemorrhagic
shock compared to controls. In skeletal muscle increases in pyruvate over
time were seen in endotoxemic shock (P = 0.003 compared to C group,
P = 0.032 compared to H group), but no changes were seen during
hemorrhagic shock. Significant differences for individual time points are
marked * for C versus H, + for C versus E, x for H versus E. C, control
group; E, endotoxemic group; H, hemorhagic group.
Figure 3 A) Myocardial and B) skeletal muscle lactate
concentrations. t0 refers to baseline measurements prior to
induction of endotoxemic or hemorrhagic shock. Significant
increases over time in cardiac and skeletal muscle lactate were seen
in both endotoxemic and hemorrhagic shock. Significant differences
for individual time points are marked * for C versus H, + for C versus
E, x for H versus E. C, control group; E, endotoxemic group; H,
hemorrhagic group.
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skeletal muscle have different metabolic signatures that are
dependent on the type of shock.
While FFAs are known to be the preferred energy
substrate for the heart [12], under stressed conditions
other energy substrates may be preferentially used dur-
ing oxidative metabolism. Sustained, enhanced non-oxi-
dative glucose utilization has also been reported in
models of ischemia-reperfusion [15]. There is indication
that an enhanced utilization of exogenous glucose
improves cardiac function during hypoxic states without
increasing total glycolytic flux or tissue high-energy
phosphate levels, representing a novel cardioprotective
mechanism [16]. This ‘metabolic flexibility’ has been
thought to confer an advantage to the heart where there
is a constant and high energy requirement. Indeed, loss
of metabolic flexibility has been shown to be deleterious
in chronic conditions, such as hypertension induced
congestive heart failure and diabetic cardiomyopathy, in
experimental models [11,17].
Another relevant question identified by these findings
is whether the decrease in myocardial glucose concentra-
tions may be associated with cardiac dysfunction. While
we demonstrated significant impairment in both left and
right ventricular function measured using echocardiogra-
phy, all of the measured indices are, to different extents,
preload dependent. Hence, we refrained from any further
analysis of the relationship between cardiac function and
metabolic parameters. A longer observation period with
low concentrations of myocardial glucose may have
revealed a depletion of myocardial energy stores and
been associated with further decreases in cardiac func-
tion. There was a concurrent rise in myocardial pyruvate,
suggesting either the conversion of glucose or lactate into
pyruvate for use in the tricarboxylic acid cycle.
This study supports the concept of accelerated aerobic
glycolysis in the myocardium where the rate of glucose
metabolism exceeds the oxidative capacity of the mito-
chondria. Thus, glucose is converted to pyruvate, whose
concentration rises and drives the production of lactate
with resultant normal L:P ratios. This was particularly
observed during endotoxemic shock with about four-
fold increases in pyruvate, accompanying increases in
interstitial lactate and low L:P ratios. This increase in
pyruvate may be an adaptive mechanism since pyruvate
in supraphysiological concentrations has been shown to
increase cardiac contractile performance and myocardial
energy state and protect the myocardium from ische-
mia-reperfusion injury and oxidant stress [18]. A key
link here may be pyruvate dehydrogenase (PDH) kinase.
PDH kinase inhibits PDH and, hence, pyruvate decar-
boxylation, a key and irreversible step in carbohydrate
oxidation. PDH kinase activity is increased by low car-
bohydrate reserves [4,11,19], consistent with the findings
of high interstitial pyruvate and low interstitial glucose
in this study.
There was no evidence of myocardial ischemia during
shock from endotoxemia or hemorrhage despite signifi-
cant hemodynamic alterations particularly in the latter
group. Hence, further support is provided for Levy et al.’s
landmark studies [9,20,21] which demonstrated the con-
cept of accelerated glycolysis via Na+K+ATPase stimula-
tion in skeletal muscle. We now show that the same
process occurs in the heart, an organ with high metabolic
demands and accounting for only a small amount of total
body lactate production.
Myocardial metabolism of energy substrates is altered
in the setting of increased cardiac work and inflamma-
tion [5-7,17]. In isolated perfused rat hearts, impaired
glucose metabolism was demonstrated when alternative
energy substrates were present, specifically glycolysis
and glycogen synthesis were impaired [7]. In patients
Figure 4 A) Myocardial and B) skeletal muscle L:P ratios. t0
refers to baseline measurements prior to induction of endotoxemic
or hemorrhagic shock. No differences over time were observed
during endotoxemic shock. In contrast, hemorrhagic shock tended
to increase L:P in skeletal muscle (P = 0.061 for mean difference,
P = 0.014 for maximum difference compared to E group). Significant
differences for individual time points are marked * for C versus H, +
for C versus E, x for H versus E. C, control group; E, endotoxemic
group; H, hemorrhagic group; L:P, lactate pyruvate ratio.
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with septic shock, Dhainaut et al. demonstrated
increases in myocardial lactate uptake and decreases in
free fatty acid and glucose utilization measured in cor-
onary sinus blood [5]. The increase in lactate uptake is
notable, since the study could not identify whether this
shift to lactate extraction was merely a reflection of
increased A-lac levels. A positive lactate gradient in the
endotoxemia group compared to the hemorrhage group
suggests that the myocardium itself produces lactate
during endotoxemia and may be part of a metabolic
switch in order to ensure substrate availability to this
organ. However, we also found that increased interstitial
lactate concentrations reflected arterial levels in both
types of shock. The finding of increased lactate and pyr-
uvate is consistent with Taegtmeyer’s concept of the
heart being a ‘metabolic omnivore’[11], switching energy
substrates to maintain metabolic flexibility. This protec-
tive mechanism allowing the body to use other sub-
strates for the generation of energy in the face of
increased metabolic needs could explain why cardiac
function was preserved in our study despite hemody-
namic compromise. Indeed enzymatic depletion of lac-
tate has been shown to cause decreased myocardial
performance, cardiovascular collapse and increased mor-
tality in a rat model of endotoxic shock [20]. An attrac-
tive hypothesis is that of a switch from fatty acid to
glucose metabolism as a mechanism for cardioprotec-
tion, as seen in hibernating hearts [11].
There are a number of limitations to this study. Firstly,
there are important differences between endotoxemic and
septic shock and findings here may not be generalizable to
patients with sepsis. However, this was a proof-of-concept
study and endotoxemia is a valid model for demonstrating
that myocardial concentrations of major energy substrates
are affected by major inflammatory insults. The endotoxe-
mic and hemorrhagic shock groups had different temporal
hemodynamic profiles with endotoxic shock animals
experiencing less severe decreases in MAP and SmvO2,
and greater increases in MPAP and A-lac levels. Hence,
the two groups are difficult to compare and the findings
here should be interpreted cautiously. The increases in
myocardial pyruvate levels in the control group were
unexpected and we speculated if it could have been a
result of anesthesia, sternotomy and fluid resuscitation
with Ringer’s lactate. However, all animals were subjected
to the same anesthesia and surgical procedures. Further
increases in pyruvate were only seen in cardiac muscle. In
a previous (unpublished) LPS dose-finding study we tested
resuscitation with 0.9% saline (n = 4) and 5% albumin (n =
3), with similar results seen for pyruvate measurements in
the myocardium. Hence, it is unlikely that this phenom-
enon is due to the administration of Ringer’s acetate. It
would be relevant to study the contribution of other
energy substrates in the heart, such as FFAs, ketones and
glycogen, which were not available using the present
microdialysis technique. In line with this, it would also
have been relevant to measure myocardial ATP levels.
Further, while we have been able to measure substrate
availability using microdialysis, we did not study their
uptake or oxidation per se. Hence, any changes in sub-
strate concentrations observed here cannot be ascribed to
changes in delivery, uptake or consumption. This would
be relevant in future research and requires measurement
of regional flow and the use of labeled isotope which was
beyond the scope of the present study. Finally, the obser-
vation time for this study was six hours post-induction of
shock, and the changes here represent only the acute
situation. These findings may be altered in the setting of
hypodynamic, endotoxemic shock. A longer observation
period may have revealed different results and allowed the
investigation of prolonged interstitial metabolic changes
on cardiac function. In addition, there may have been dif-
ferences between the right and left heart that were beyond
the scope of this study.
Although we have used currently accepted echocardio-
graphic indices for the measurement of systolic and dia-
stolic function, all echo data provided in the present
study are preload, afterload and HR dependent. It is,
therefore, difficult, if at all possible, to differentiate
between direct myocardial systolic and diastolic effects of
endotoxemia from secondary effects caused by endotoxe-
mia-induced changes in preload, afterload or heart rate.
Notwithstanding the limitations above, microdialysis
provides a unique possibility for studying the temporal
changes in metabolism directly in tissues. We demon-
strate these changes for the first time in the heart, com-
paring it to a different metabolically active organ, and in
two different types of shock. A logical extension to this
study would be to investigate changes during hypody-
namic septic shock and during overt myocardial dys-
function, to monitor responses during resuscitation, as
well as to extend MD studies to other organs.
Conclusions
Endotoxemic and hemorrhagic shock induce profound
changes in myocardial energy substrates, characterized
by up to four-fold increases in interstitial pyruvate and
three-fold increases in interstitial lactate. Endotoxemic,
but not hemorrhagic, shock was characterized by a pre-
cipitous decrease in myocardial glucose. In skeletal mus-
cle similar patterns were seen during endotoxemic
shock with decreases in glucose and increases in pyru-
vate and lactate concentrations. However, during
hemorrhagic shock, the skeletal muscle response differed
and was characterized by a lack of increase in pyruvate.
Taken together, these findings suggest that the heart
and skeletal muscle respond in metabolically distinct
fashions in different types of shock.
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Key messages
• Endotoxemic shock causes a severe and precipitous
decrease in myocardial glucose concentrations
• Despite the decrease in glucose, myocardial pyru-
vate and lactate concentrations are simultaneously
increased in both types of shock
• Skeletal muscle responds differently with no
increases in pyruvate seen in hemorrhagic shock
• Taken together, these findings suggest that the
heart responds in a metabolically distinct fashion in
endotoxemic and hemorrhagic shock
• The finding of increased lactate and pyruvate is
consistent with Taegtmeyer’s concept of the heart
being a ‘metabolic omnivore’, switching energy sub-
strates to maintain metabolic flexibility
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